Open procedure for the award of services to a contract research organization (CRO) for the management of the multicentre randomized clinical trial: “COMBOSEQ – Sequence Strategy of Immuno-Oncology (IO-IO) vs. IO-Tyrosine Kinase Inhibitors (TKI) Followed by TKI in Metastatic Renal Cell Carcinoma (mRCC): A Randomized Phase 3 Study MEETURO and FICOG Trial”, via the Sintel platform
Fondazione Irccs Istituto Nazionale dei Tumori, MilanoTED 766672-2026
€2,024,0001 lot
Tue 24 Nov12:00 in Rome
15days